Christopher H. Van Buren

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Livent Corporation of $225 million aggregate principal amount of its 4.125%…

Davis Polk advised the joint book-running managers in connection with a Rule 144A/Regulation S notes offering by Sands China Ltd. of $800 million of its 3.800% senior notes due 2026…

Davis Polk advised the representatives of the underwriters in connection with the $70 million follow-on public offering of 5,000,000 shares of common stock of TransMedics Group, Inc…

Davis Polk advised the joint book-running managers in connection with a registered offering by Eli Lilly and Company of $1.0 billion aggregate principal amount of its 2.250% notes due 2050…

Davis Polk advised the underwriter in connection with the $59.9 million secondary offering of 2,678,049 shares of common stock of TriState Capital Holdings, Inc. by selling shareholders LM…

Davis Polk advised the underwriters in connection with the SEC-registered notes offering by Las Vegas Sands Corp. of $500 million of its 2.900% senior notes due 2025. Las Vegas Sands…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 9,487,500 shares of common stock of…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered offering by Steelcase Inc. of $450 million principal…

Davis Polk advised Marsh & McLennan Companies, Inc. in connection with its SEC-registered offering of $5 billion aggregate principal amount of its $700 million aggregate principal…

Davis Polk advised FMC Corporation in connection with the separation of its lithium division into a new publicly traded company, to be called Livent Corporation, and advised Livent in…